2024 Wuzhen Health Conference: Social Media Insights and Digital Marketing Analysis for China's Health & Wellness Industry

Key Finding 1

China's health & wellness industry generated over CN¥ 75.2 billion in online sales during the March 2023 to February 2024 period, with social media mention volume peaking at 34.5 million posts in January 2024 -- signaling sustained consumer demand across six rising segments.

The health & wellness market demonstrates a dual trajectory: robust e-commerce sales punctuated by seasonal spikes (November 2023 sales exceeded CN¥ 9.2 billion) alongside accelerating social media engagement that reveals shifting consumer priorities. Six distinct segments -- dietary supplements, probiotics, traditional Chinese medicine (TCM) ingredients, infant nutrition, joint health products, and functional foods -- each show differentiated growth patterns that create targeted opportunities for brands. The divergence between mention volume (which trended upward) and engagement volume (which declined in H2 2023) suggests consumers increasingly seek information-rich content over passive scrolling, favoring professional-grade health guidance.

Key Finding 2

Mood-regulating probiotics are breaking out of their female-dominated niche: male discussion share surged from 29.4% to 44.5% year-on-year, while the category penetrates from Tier 1 cities (down from 51.8% to 48.8% share) into lower-tier markets.

The audience profile for mood-regulating probiotics underwent significant expansion during the study period. The core demographic remained women aged 26-35, but the rapid increase in male participation signals a broadening value proposition beyond traditional gut health. Anxiety/stress (21.8%) and poor sleep quality (22.5%) together dominated symptom discussions, while emerging concepts such as children's focus/attention exhibited explosive +16,000% year-on-year growth in sales revenue -- revealing a nascent but high-potential sub-segment. Brands that position mood-regulation probiotics as multi-demographic wellness solutions, rather than niche supplements, stand to capture the widest market opportunity.

Key Finding 3

Under the cordyceps topic, the deer blood + cordyceps combination achieved +357.8% year-on-year sales revenue growth despite low baseline awareness, while cough relief/lung nourishment and qi/blood nourishment together commanded over 54% of efficacy discussions.

Social media analysis of cordyceps reveals a market segmented by maturity: high-volume ingredients like ginseng (76,487 mentions) and bird's nest (75,270 mentions) anchor established consumer awareness, while emerging combinations such as deer blood + cordyceps and deer antler + cordyceps (+258.2% growth) represent frontier growth opportunities. Post-pandemic health consciousness has amplified demand for respiratory-related benefits, positioning cordyceps products that emphasize lung nourishment for sustained growth. Ingredient pairing discussions led all dimensions at 23.2%, indicating that consumers increasingly view cordyceps as a versatile ingredient within broader wellness routines rather than a standalone supplement.

Key Finding 4

In the infant formula market, Professional Generated Content (PGC) prioritized ingredients at 36.3% of attention share, while User Generated Content (UGC) focused on demographics (31.8%) and raised side-effect concerns (6.5% versus 2.8% in PGC) -- exposing a critical trust gap that brands must address.

The PGC-UGC divergence in infant formula discussions reveals a fundamental disconnect: brands and professionals promote advanced ingredient innovations (HMO, A2 protein, GOS), yet real parents prioritize safety and tolerability. Lactoferrin, probiotics, and DHA dominate both content types with over 12,000 UGC mentions each, indicating strong baseline awareness. However, the significantly higher UGC attention to side effects -- with "allergy" (8,247 mentions), "constipation" (6,916 mentions), and "diarrhea" (5,044 mentions) ranking prominently -- highlights the trust-building work required for brands promoting emerging ingredient formulations.